Affiliated Hospital of Guizhou Vocational Nursing Technology College
Guiyang, Guizhou, 550025, China
NCT Number: NCT06674603
Introduction:Delirium is a prevalent psychiatric disorder observed in the Intensive Care unit(ICU) hat; often aggravates patients; overall health status, extends the duration of mechanical ventilation, prolongs ICU stays, and causes persistent or long-term cognitive impairment. A plethora of studies have indicated that the frequency, duration, and severity of delirium during hospitalization are significant risk factors for cognitive impairment in patients following transfer from the ICU. However, existing research has predominantly focused on cross-sectional analyses without delving into the influencing factors among patient subgroups. Consequently, the aim of this study is to employ the Latent Growth Curve Model (LGCM) and the Latent Class Growth Model (LCGM) model to analyze the trajectory of cognitive development and influencing factors of patients with delirium in the ICU one year after discharge.
Methods and analysis:This prospective study aims to investigate the trajectory of cognitive level variations of patients with delirium in ICU for one year. It is planned to recruit 240 participants and gather comprehensive data including general demographics, disease-related information, scores from the Minimum Mental State Examination, Hospital Anxiety and Depression Scale, and the Pittsburgh Sleep Quality Index. All data will be followed up using the same schedule on the day of transfer, 1 month after transfer, 3 months after transfer, 6 months after transfer and 1 year after transfer. Ultimately, the investigators will employ Latent Growth Curve Model and Latent Class Growth Model to analyze the trajectory of cognitive changes and identify potential categories, in addition to utilizing logistic regression modeling to explore influencing factors. The results of this study provide a theoretical framework for the clinical implementation of precision nursing interventions within this demographic, so as to prevent and reduce the decline of cognitive function and improve the quality of life of patients.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Guiyang, Guizhou, 550025, China
A prospective longitudinal cohort study will be conducted in the ICU of a tertiary grade-A hospital in Guizhou Province. The study aims to recruit 240 patients diagnosed with ICU delirium, who were carefully selected based on predefined inclusion and exclusion criteria (Inclusion and exclusion criteria were as follows). The study is anticipated to commence in September 2024 and conclude in May 2026.
The inclusion criteria are:
The exclusion criteria are:
Follow-up data collection: at the time of patient transfer, the research team remains in contact with the participants and tracks their whereabouts and rehabilitation outcomes after discharge. Follow-up visits are conducted on the day of transfer (T1), 1 month after transfer (T2), 3 months after transfer (T3), 6 months after transfer (T4), and 1 year after transfer (T5) (see Table 4). Members of our study team will provide one-on-one contact with patients via WeChat video or face-to-face follow-up. Participants or family members are deemed disengaged if they are unwilling to cooperate in the study.
Outcome measures: cognitive level, anxiety and depression level and sleep status of delirium patients after discharge. Minimum Mental State Examination, Hospital Anxiety and Depression Scale and Pittsburgh sleep quality index will be used for measurement.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
The inclusion criteria are:
The exclusion criteria are:
Time frame: from the day the patient was transferred out of the ICU to the end of the year.
cognitive level will be assessed using the MMSE scale. The scale is designed to assess five aspects, namely orientation, memory, attention and calculation, recall, and language, with a total of score 30 points. The cognitive functioning improves as the score increases, with scores ranging from 27 to 30 being normal, and scores below 27 indicating cognitive dysfunction.The higher the score, the better the cognitive status of patients.
Time frame: from the day the patient was transferred out of the ICU to the end of the year.
The scale is utilized for evaluating the extent of anxiety and depression present in patients.The scale contains 14 entries, including 2 subscales for anxiety and depression, with 7 entries rating depression and 7 entries rating anxiety. The total score of both subscales ranges from 0 to 7 for no anxiety or depression, 8 to 10 for critical anxiety or depression, and 11 to 21 for significant anxiety or depression.
Time frame: from the day the patient was transferred out of the ICU to the end of the year.
The scale evaluate a patient's quality of sleep in the last month. Each entry was rated on a scale of 0 to 3, summing up to a total score between 0 and 21, where higher scores signify a deterioration in sleep quality.
Zunyi Medical College
Other
The Trajectory and Influencing Factors of Cognitive Level in ICU Delirium Patients After Transfer Out of the ICU: Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04289142
Analgesics, Analgesics, Non-Narcotic
Vancouver, British Columbia, Canada
View Trial DetailsNCT06268080
Anesthesia, Cognition Disorder
Grafton, Auckland, New Zealand
View Trial DetailsNCT05831839
Attention Deficit, Attention Deficit Disorder with Hyperactivity
Rotterdam, South Holland, Netherlands
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial Details